Peter Borchmann
University Hospital of Cologne
Germany
Peter Borchmann is Assistant Medical Director in the Department of Haematology and Oncology at the University Hospital of Cologne, Germany and head of the lymphoma programme including the CAR T-cell therapy phase I/II unit. He is head of the certified centre for haematological malignancies of the University Hospital of Cologne, Germany. As Co-Chairman of the German Hodgkin Study Group (GHSG) he is responsible for the development of investigator initiated clinical studies. He is an active member of the German Society for Haematology and Oncology (DGHO), the European Haematology Association (EHA), and the American Society of Haematology (ASH).
Last update:
September 2020